Physician

Trina Poretta, D.O.

According to 2025 Medicare claims, Trina Poretta, D.O. (NPI: 1720082092) practices hematology/oncology in the Camden, NJ market, with the plurality of this provider's patient population coming from Camden, NJ. This provider's primary affiliated billing organization is COMPREHENSIVE CANCER & HEMATOLOGY SPECIALISTS, P.C. (NPI: 1932106580; TIN: 521676914) and primary practice location at 08043-2468.

Poretta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 636 traditional Medicare patients, billed 179,016 HCPCS/CPT codes, and received $1,264,835 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,643 prescription claims across 355 beneficiaries totaling $11,411,057 in drug costs, led by Jakafi (Ruxolitinib Phosphate). DME data shows 51 claims. Open Payments data shows 183 records totaling $3,676. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $1,765,814 to $1,264,835. In contrast, Part D prescription costs have moved sharply higher in recent years, from $1,209,178 to $11,411,057. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.2M2015 Medicare payment: $1,765,814 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,022,854 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,202,923 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,030,999 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,636,627 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,830,906 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,672,620 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $982,536 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,277,868 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,264,835 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015888165,319$1,765,814
2016977171,604$2,022,854
20171,078167,450$2,202,923
2018883185,617$2,030,999
2019735147,073$1,636,627
2020685158,406$1,830,906
2021600151,247$1,672,620
2022612137,140$982,536
2023618156,190$1,277,868
2024636179,016$1,264,835

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$5.7M$11M2015 Drug cost: $1,209,178 (USD; Tot_Drug_Cst)2016 Drug cost: $1,167,044 (USD; Tot_Drug_Cst)2017 Drug cost: $1,619,866 (USD; Tot_Drug_Cst)2018 Drug cost: $2,187,648 (USD; Tot_Drug_Cst)2019 Drug cost: $2,994,742 (USD; Tot_Drug_Cst)2020 Drug cost: $5,038,258 (USD; Tot_Drug_Cst)2021 Drug cost: $8,003,105 (USD; Tot_Drug_Cst)2022 Drug cost: $8,096,856 (USD; Tot_Drug_Cst)2023 Drug cost: $9,177,572 (USD; Tot_Drug_Cst)2024 Drug cost: $11,411,057 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015224980$1,209,178
2016235971$1,167,044
20172331,034$1,619,866
20182841,249$2,187,648
20193051,399$2,994,742
20203612,228$5,038,258
20213642,738$8,003,105
20223322,539$8,096,856
20233482,350$9,177,572
20243552,643$11,411,057

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$13K$26K2015 Medicare payment: $25,696 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $4,548 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $17,969 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $5,946 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $13,810 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $8,074 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $9,117 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $4,201 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $19,918 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $942 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R85$25,696
20161164$4,548
2017N/R46$17,969
2018N/R19$5,946
20191188$13,810
2020N/R89$8,074
202111141$9,117
202229141$4,201
202326137$19,918
2024N/R51$942

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more289504$102
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more393905$68
96372Injection of drug or substance under skin or into muscle115425$12
36415Insertion of needle into vein for collection of blood sample295720$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count3251,018$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JakafiRuxolitinib Phosphate421,260$768,541
IbrancePalbociclib451,260$730,022
ImbruvicaIbrutinib551,540$728,112
RevlimidLenalidomide391,092$709,716
Darzalex FasproDaratumumab-Hyaluronidase-Fihj561,169$610,437

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R18$428
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R21$376
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R12$138

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.183$3,676PFIZER INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Trina Poretta, D.O.?

Tedicare shows public-source Medicare data for Trina Poretta, D.O. (NPI 1720082092), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Trina Poretta, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Trina Poretta, D.O.?

Trina Poretta, D.O. is linked to COMPREHENSIVE CANCER & HEMATOLOGY SPECIALISTS, P.C. (billing NPI 1932106580) in the available physician profile data.

Does Trina Poretta, D.O. have Open Payments data?

Trina Poretta, D.O. has 183 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.